Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Non-cash Items (2018 - 2025)

Fennec Pharmaceuticals' Non-cash Items history spans 4 years, with the latest figure at $4.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 15.88% year-over-year to $4.2 million, compared with a TTM value of $4.2 million through Dec 2025, down 15.88%, and an annual FY2025 reading of $4.2 million, down 15.88% over the prior year.
  • Non-cash Items for Q4 2025 was $4.2 million at Fennec Pharmaceuticals, down from $5.0 million in the prior quarter.
  • The five-year high for Non-cash Items was $5.0 million in Q4 2024, with the low at $4.2 million in Q4 2025.